Seeking Alpha

Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced it filed a complaint with the U.S. International Trade Commission (ITC), along ...
Business Wire

Axonics® Announces U.S. Food & Drug Administration Approves Use of Full-Body MRI for Pivotal Study Patients

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable sacral ...
elEconomista

Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation ("SNM") devices for the ...
Business Wire

Axonics Reports Second Quarter 2024 Financial Results

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder ...
pharmaphorum

NICE backs Axonics’ rechargeable device for overactive bladder

A device to treat urinary incontinence made by US biotech Axonics has been recommended for NHS use by NICE, which says it could save thousands of pounds in healthcare costs. The implantable Axonics ...